Androgens and skeletal muscle: Cellular and molecular action mechanisms underlying the anabolic actions

Cellular and Molecular Life Sciences

Volumn 69, Issue 10, 2012, Pages 1651-1667

  Dubois, Vanessa ^a   Laurent, Michaël ^a   Boonen, Steven ^a   Vanderschueren, Dirk ^a   Claessens, Frank ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Androgen receptor; Androgens; IGF I; Myostatin; Non genomic signaling; Satellite cells; Skeletal muscle

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CELL CYCLE PROTEIN; CELL NUCLEUS RECEPTOR; FOLLISTATIN; MYOSTATIN; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SELECTIVE ANDROGEN RECEPTOR MODULATOR; SERUM RESPONSE FACTOR; SOMATOMEDIN C; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR FOXO; TRANSFORMING GROWTH FACTOR BETA;

CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL PROLIFERATION; DIMERIZATION; DOWN REGULATION; ENZYME ACTIVITY; GENE CONTROL; HUMAN; MESENCHYME CELL; MOTONEURON; MUSCLE CELL; MYOBLAST; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; SATELLITE CELL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSCRIPTION REGULATION; UPREGULATION;

ANABOLIC AGENTS; ANDROGENS; CELL PROLIFERATION; MODELS, BIOLOGICAL; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION;

EID: 84863561473     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-011-0883-3     Document Type: Review

References (194)

1. Yin D, Gao W, Kearbey JD, Xu H, Chung K, He Y, Marhefka CA, Veverka KA, Miller DD, Dalton JT (2003) Pharmacody-namics of selective androgen receptor modulators. J Pharmacol Exp Ther 304:1334-1340 (Pubitemid 36254449)
2. Bhasin S, Woodhouse L, Storer TW (2003) Androgen effects on body composition. Growth Horm IGF Res 13 (Suppl A):S63-S71 (Pubitemid 37161660)
3. Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, Bunnell TJ, Tricker R, Shirazi A, Casaburi R (1996) The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 335:1-7 (Pubitemid 26230806)
4. Bhasin S, Woodhouse L, Casaburi R, Singh AB, Mac RP, Lee M, Yarasheski KE, Sinha-Hikim I, Dzekov C, Dzekov J, Magliano L, Storer TW (2005) Older men are as responsive as young men to the anabolic effects of graded doses of testos-terone on the skeletal muscle. J Clin Endocrinol Metab 90:678-688 (Pubitemid 40279179)
5. Sinha-Hikim I, Artaza J, Woodhouse L, Gonzalez-Cadavid N, Singh AB, Lee MI, Storer TW, Casaburi R, Shen R, Bhasin S (2002) Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab 283:E154-E164 (Pubitemid 34686681)
6. MacLean HE, Handelsman DJ (2009) Unraveling androgen action in muscle: genetic tools probing cellular mechanisms. Endocrinology 150:3437-3439
7. Cawthon PM, Ensrud KE, Laughlin GA, Cauley JA, Dam TT, Barrett-Connor E, Fink HA, Hoffman AR, Lau E, Lane NE, Stefanick ML, Cummings SR, Orwoll ES (2009) Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study. J Clin Endocrinol Metab 94:3806-3815
8. Srinivas-Shankar U, Roberts SA, Connolly MJ, O'Connell MD, Adams JE, Oldham JA, Wu FC (2010) Effects oftestosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 95:639-650
9. Bhasin S, Calof OM, Storer TW, Lee ML, Mazer NA, Jasuja R, Montori VM, Gao W, Dalton JT (2006) Drug insight: testos-terone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat Clin Pract Endo-crinol Metab 2:146-159
10. Ferrando AA, Sheffield-Moore M, Yeckel CW, Gilkison C, Jiang J, Achacosa A, Lieberman SA, Tipton K, Wolfe RR, Urban RJ (2002) Testosterone administration to older men improves muscle function: molecular and physiological mech-anisms. Am J Physiol Endocrinol Metab 282:E601-E607 (Pubitemid 34654776)
11. Bhasin S, Storer TW, Javanbakht M, Berman N, Yarasheski KE, Phillips J, Dike M, Sinha-Hikim I, Shen R, Hays RD, Beall G (2000) Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. JAMA 283:763-770 (Pubitemid 30084616)
12. Storer TW, Woodhouse L, Magliano L, Singh AB, Dzekov C, Dzekov J, Bhasin S (2008) Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men. J Am Geriatr Soc 56:1991-1999
13. Urban RJ, Bodenburg YH, Gilkison C, Foxworth J, Coggan AR, Wolfe RR, Ferrando A (1995) Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol 269:E820-E826 (Pubitemid 3005899)
14. Ferrando AA, Tipton KD, Doyle D, Phillips SM, Cortiella J, Wolfe RR (1998) Testosterone injection stimulates net protein synthesis but not tissue amino acid transport. Am J Physiol 275:E864-E871
15. Sheffield-Moore M, Urban RJ, Wolf SE, Jiang J, Catlin DH, Herndon DN, Wolfe RR, Ferrando AA (1999) Short-term oxandrolone administration stimulates net muscle protein synthesis in young men. J Clin Endocrinol Metab 84:2705-2711 (Pubitemid 30641997)
16. Ferrando AA, Sheffield-Moore M, Paddon-Jones D, Wolfe RR, Urban RJ (2003) Differential anabolic effects oftestosterone and amino acid feeding in older men. J Clin Endocrinol Metab 88:358-362 (Pubitemid 36115189)
17. Wittert GA, Chapman IM, Haren MT, Mackintosh S, Coates P, Morley JE (2003) Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol A Biol Sci Med Sci 58:618-625 (Pubitemid 36900168)
18. Claessens F, Denayer S, Van Tilborgh N, Kerkhofs S, Helsen C, Haelens A (2008) Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nucl Recept Signal 6:e008
19. Lewis MI, Horvitz GD, Clemmons DR, Fournier M (2002) Role of IGF-I and IGF-binding proteins within diaphragm muscle in modulating the effects of nandrolone. Am J Physiol Endocrinol Metab 282:E483-E490 (Pubitemid 34654820)
20. Estrada M, Liberona JL, Miranda M, Jaimovich E (2000) Aldosterone- and testosterone-mediated intracellular calcium response in skeletal muscle cell cultures. Am J Physiol Endo-crinol Metab 279:E132-E139 (Pubitemid 30609954)
21. Callewaert F, Sinnesael M, Gielen E, Boonen S, Vanderschu-eren D (2010) Skeletal sexual dimorphism: relative contribution of sex steroids, GH-IGF1, and mechanical loading. J Endocrinol 207:127-134
22. Lubischer JL, Bebinger DM (1999) Regulation of terminal Schwann cell number at the adult neuromuscular junction. J Neurosci 19: RC46
23. Monks DA, O'Bryant EL, Jordan CL (2004) Androgen receptor immunoreactivity in skeletal muscle: enrichment at the neuro-muscular junction. J Comp Neurol 473:59-72 (Pubitemid 38507119)
24. Johansen JA, Breedlove SM, Jordan CL (2007) Androgen receptor expression in the levator ani muscle of male mice. J Neuroendocrinol 19:823-826 (Pubitemid 47386884)
25. Charge SB, Rudnicki MA (2004) Cellular and molecular regu-lation of muscle regeneration. Physiol Rev 84:209-238 (Pubitemid 38049880)
26. Chen Y, Zajac JD, MacLean HE (2005) Androgen regulation of satellite cell function. J Endocrinol 186:21-31 (Pubitemid 41015661)
27. Sinha-Hikim I, Taylor WE, Gonzalez-Cadavid NF, Zheng W, Bhasin S (2004) Androgen receptor in human skeletal muscle and cultured muscle satellite cells: up-regulation by androgen treatment. J Clin Endocrinol Metab 89:5245-5255 (Pubitemid 39391474)
28. Niel L, Willemsen KR, Volante SN, Monks DA (2008) Sexual dimorphism and androgen regulation of satellite cell population in differentiating rat levator ani muscle. Dev Neurobiol 68:115-122
29. Matsumoto A, Arai Y, Prins GS (1996) Androgenic regulation of androgen receptor immunoreactivity in motoneurons of the spinal nucleus of the bulbocavernosus of male rats. J Neuroen-docrinol 8:553-559 (Pubitemid 26239723)
30. Mauro A (1961) Satellite cell of skeletal muscle fibers. J Bio-phys Biochem Cytol 9:493-495
31. Montarras D, Morgan J, Collins C, Relaix F, Zaffran S, Cumano A, Partridge T, Buckingham M (2005) Direct isolation of satellite cells for skeletal muscle regeneration. Science 309:2064-2067 (Pubitemid 41362326)
32. Fukada S, Higuchi S, Segawa M, Koda K, Yamamoto Y, Tsu-jikawa K, Kohama Y, Uezumi A, Imamura M, Miyagoe-Suzuki Y, Takeda S, Yamamoto H (2004) Purification and cell-surface marker characterization of quiescent satellite cells from murine skeletal muscle by a novel monoclonal antibody. Exp Cell Res 296:245-255 (Pubitemid 38624645)
33. Gnocchi VF, White RB, Ono Y, Ellis JA, Zammit PS (2009) Further characterisation of the molecular signature of quiescent and activated mouse muscle satellite cells. PLoS One 4:e5205
34. Hughes VA, Frontera WR, Roubenoff R, Evans WJ, Singh MA (2002) Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr 76:473-481 (Pubitemid 34804075)
35. Brooks NE, Schuenke MD, Hikida RS (2009) No change in skeletal muscle satellite cells in young and aging rat soleus muscle. J Physiol Sci 59:465-471
36. Day K, Shefer G, Shearer A, Yablonka-Reuveni Z (2010) The depletion of skeletal muscle satellite cells with age is concom-itant with reduced capacity of single progenitors to produce reserve progeny. Dev Biol 340:330-343
37. Grounds MD (1998) Age-associated changes in the response of skeletal muscle cells to exercise and regeneration. Ann N Y Acad Sci 854:78-91 (Pubitemid 29022795)
38. Welle S (2002) Cellular and molecular basis of age-related sarcopenia. Can J Appl Physiol 27:19-41
39. Conboy IM, Conboy MJ, Smythe GM, Rando TA (2003) Notch-mediated restoration of regenerative potential to aged muscle. Science 302:1575-1577 (Pubitemid 37475703)
40. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA (2005) Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433:760-764 (Pubitemid 40292986)
41. Filippin LI, Moreira AJ, Marroni NP, Xavier RM (2009) Nitric oxide and repair of skeletal muscle injury. Nitric Oxide 21:157-163
42. Pedersen BK, Edward F (2009) Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines. J Appl Physiol 107:1006-1014
43. Conboy IM, Rando TA (2002) The regulation of Notch signal-ing controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev Cell 3:397-409
44. Buas MF, Kadesch T (2010) Regulation of skeletal myogenesis by Notch. Exp Cell Res 316:3028-3033
45. Tsivitse S (2010) Notch and Wnt signaling, physiological stimuli and postnatal myogenesis. Int J Biol Sci 6:268-281
46. Sinha-Hikim I, Roth SM, Lee MI, Bhasin S (2003) Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. Am J Physiol Endocrinol Metab 285:E197-E205 (Pubitemid 36736377)
47. Sinha-Hikim I, Cornford M, Gaytan H, Lee ML, Bhasin S (2006) Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older men. J Clin Endocrinol Metab 91:3024-3033 (Pubitemid 44271751)
48. Doumit ME, Cook DR, Merkel RA (1996) Testosterone up-regulates androgen receptors and decreases differentiation of porcine myogenic satellite cells in vitro. Endocrinology 137:1385-1394 (Pubitemid 26095257)
49. Joubert Y, Tobin C (1989) Satellite cell proliferation and increase in the number of myonuclei induced by testosterone in the levator ani muscle of the adult female rat Dev Biol 131:550-557
50. Joubert Y, Tobin C, Lebart MC (1994) Testosterone-induced masculinization of the rat levator ani muscle during puberty. Dev Biol 162:104-110 (Pubitemid 24098535)
51. Mulvaney DR, Marple DN, Merkel RA (1988) Proliferation of skeletal muscle satellite cells after castration and administration oftestosterone propionate. Proc Soc Exp Biol Med 188:40-45
52. Powers ML, Florini JR (1975) A direct effect oftestosterone on muscle cells in tissue culture. Endocrinology 97:1043-1047
53. Diel P, Baadners D, Schlupmann K, Velders M, Schwarz JP (2008) C2C12 myoblastoma cell differentiation and prolifera-tion is stimulated by androgens and associated with a modulation of myostatin and Pax7 expression. J Mol Endocrinol 40:231-241 (Pubitemid 351865031)
54. Chen Y, Lee NK, Zajac JD, MacLean HE (2008) Generation and analysis of an androgen-responsive myoblast cell line indicates that androgens regulate myotube protein accretion. J Endocrinol Invest 31:910-918
55. Desler MM, Jones SJ, Smith CW, Woods TL (1996) Effects of dexamethasone and anabolic agents on proliferation and protein synthesis and degradation in C2C12 myogenic cells. J Anim Sci 74:1265-1273 (Pubitemid 126428704)
56. KIP2 control muscle differentiation at the myogenin step. Genes Dev 13:213-224 (Pubitemid 29061951)
57. Schmid C, Steiner T, Froesch ER (1983) Preferential enhance-ment of myoblast differentiation by insulin-like growth factors (IGF I and IGF II) in primary cultures of chicken embryonic cells. FEBS Lett 161:117-121 (Pubitemid 13017060)
58. Li J, Mayne R, Wu C (1999) A novel muscle-specific beta 1 integrin binding protein (MIBP) that modulates myogenic dif-ferentiation. J Cell Biol 147:1391-1398
59. MacLean HE, Chiu WS, Notini AJ, Axell AM, Davey RA, McManus JF, Ma C, Plant DR, Lynch GS, Zajac JD (2008) Impaired skeletal muscle development and function in male, but not female, genomic androgen receptor knockout mice. FASEB J 22:2676-2689
60. Wannenes F, Caprio M, Gatta L, Fabbri A, Bonini S, Moretti C (2008) Androgen receptor expression during C2C12 skeletal muscle cell line differentiation. Mol Cell Endocrinol 292:11-19
61. Kamanga-Sollo E, White ME, Hathaway MR, Weber WJ, Dayton WR (2011) Effect of trenbolone acetate on protein synthesis and degradation rates in fused bovine satellite cell cultures. Domest Anim Endocrinol 40:60-66
62. Zammit PS, Partridge TA, Yablonka-Reuveni Z (2006) The skeletal muscle satellite cell: the stem cell that came in from the cold. J Histochem Cytochem 54:1177-1191 (Pubitemid 44623339)
63. De Angelis L, Berghella L, Coletta M, Lattanzi L, Zanchi M, Cusella-De Angelis MG, Ponzetto C, Cossu G (1999) Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J Cell Biol 147:869-878
64. LaBarge MA, Blau HM (2002) Biological progression from adult bone marrow to mononucleate muscle stem cell to multi-nucleate muscle fiber in response to injury. Cell 111:589-601 (Pubitemid 35356563)
65. Asakura A, Seale P, Girgis-Gabardo A, Rudnicki MA (2002) Myogenic specification of side population cells in skeletal muscle. J Cell Biol 159:123-134 (Pubitemid 35191524)
66. Tamaki T, Okada Y, Uchiyama Y, Tono K, Masuda M, Nitta M, Hoshi A, Akatsuka A (2008) Skeletal muscle-derived CD34 +/ 45- and CD34-/45- stem cells are situated hierarchically upstream of Pax7 + cells. Stem Cells Dev 17:653-667
67. Dellavalle A, Sampaolesi M, Tonlorenzi R, Tagliafico E, Sac-chetti B, Perani L, Innocenzi A, Galvez BG, Messina G, Morosetti R, Li S, Belicchi M, Peretti G, Chamberlain JS, Wright WE, Torrente Y, Ferrari S, Bianco P, Cossu G (2007) Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 9:255-267 (Pubitemid 46349927)
68. Mitchell KJ, Pannerec A, Cadot B, Parlakian A, Besson V, Gomes ER, Marazzi G, Sassoon DA (2010) Identification and characterization of a non-satellite cell muscle resident progeni-tor during postnatal development. Nat Cell Biol 12:257-266
69. Woodhouse LJ, Gupta N, Bhasin M, Singh AB, Ross R, Phillips J, Bhasin S (2004) Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men. J Clin Endocrinol Metab 89:718-726 (Pubitemid 38269883)
70. Dati E, Baroncelli GI, Mora S, Russo G, Baldinotti F, Parrini D, Erba P, Simi P, Bertelloni S (2009) Body composition and metabolic profile in women with complete androgen insensi-tivity syndrome. Sex Dev 3:188-193
71. Sato T, Matsumoto T, Yamada T, Watanabe T, Kawano H, Kato S (2003) Late onset of obesity in male androgen receptor-defi-cient (AR KO) mice. Biochem Biophys Res Commun 300:167-171 (Pubitemid 36042946)
72. Lin HY, Xu Q, Yeh S, Wang RS, Sparks JD, Chang C (2005) Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor. Diabetes 54:1717-1725 (Pubitemid 40770762)
73. Callewaert F, Venken K, Ophoff J, De Gendt K, Torcasio A, van Lenthe GH, Van Oosterwyck H, Boonen S, Bouillon R, Verhoeven G, Vanderschueren D (2009) Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor-alpha. FASEB J 23:232-240
74. Ophoff J, Callewaert F, Venken K, De Gendt K, Ohlsson C, Gayan-Ramirez G, Decramer M, Boonen S, Bouillon R, Verhoeven G, Vanderschueren D (2009) Physical activity in the androgen receptor knockout mouse: evidence for reversal of androgen deficiency on cancellous bone. Biochem Biophys Res Commun 378:139-144
75. Ophoff J, Van Proeyen K, Callewaert F, De Gendt K, De Bock K, Vanden Bosch A, Verhoeven G, Hespel P, Vanderschueren D (2009) Androgen signaling in myocytes contributes to the maintenance of muscle mass and fiber type regulation but not to muscle strength or fatigue. Endocrinology 150:3558-3566
76. Starkey JD, Yamamoto M, Yamamoto S, Goldhamer DJ (2011) Skeletal muscle satellite cells are committed to myogenesis and do not spontaneously adopt nonmyogenic fates. J Histochem Cytochem 59:33-46
77. Uezumi A, Fukada S, Yamamoto N, Takeda S, Tsuchida K (2010) Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat Cell Biol 12:143-152
78. Herbst KL, Bhasin S (2004) Testosterone action on skeletal muscle. Curr Opin Clin Nutr Metab Care 7:271-277 (Pubitemid 40340664)
79. Grounds MD, White JD, Rosenthal N, Bogoyevitch MA (2002) The role of stem cells in skeletal and cardiac muscle repair. J Histochem Cytochem 50:589-610 (Pubitemid 34437554)
80. Jankowski RJ, Deasy BM, Huard J (2002) Muscle-derived stem cells. Gene Ther 9:642-647 (Pubitemid 34575318)
81. Semirale AA, Zhang X, Wiren KM (2011) Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation. J Cell Biochem 112:1773-1786
82. Fernando SM, Rao P, Niel L, Chatterjee D, Stagljar M, Monks DA (2010) Myocyte androgen receptors increase metabolic rate and improve body composition by reducing fat mass. Endocri-nology 151:3125-3132
83. Singh R, Artaza JN, Taylor WE, Gonzalez-Cadavid NF, Bhasin S (2003) Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 144:5081-5088 (Pubitemid 37378423)
84. Singh R, Bhasin S, Braga M, Artaza JN, Pervin S, Taylor WE, Krishnan V, Sinha SK, Rajavashisth TB, Jasuja R (2009) Reg-ulation of myogenic differentiation by androgens: cross talk between androgen receptor/beta-catenin and follistatin/trans-forming growth factor-beta signaling pathways. Endocrinology 150:1259-1268
85. Narici MV, Maffulli N, Maganaris CN (2008) Ageing of human muscles and tendons. Disabil Rehabil 30:1548-1554
86. Hadi Mansouri S, Siegford JM, Ulibarri C (2003) Early post-natal response of the spinal nucleus of the bulbocavernosus and target muscles to testosterone in male gerbils. Brain Res Dev Brain Res 142:129-139 (Pubitemid 36593157)
87. Fraley GS, Ulibarri CM (2002) Long-term castration effects motoneuron size but not number in the spinal nucleus of the bulbocavernosus in the adult male Mongolian gerbil. Brain Res 953:265-271 (Pubitemid 35217828)
88. Raskin K, de Gendt K, Duittoz A, Liere P, Verhoeven G, Tronche F, Mhaouty-Kodja S (2009) Conditional inactivation of androgen receptor gene in the nervous system: effects on male behavioral and neuroendocrine responses. J Neurosci 29:4461-4470
89. Fishman RB, Breedlove SM (1988) Neonatal androgen main-tains sexually dimorphic muscles in the absence of innervation. Muscle Nerve 11:553-560
90. Rand MN, Breedlove SM (1992) Androgen locally regulates rat bulbocavernosus and levator ani size. J Neurobiol 23:17-30
91. Heemers HV, Tindall DJ (2007) Androgen receptor (AR) coregulators: a diversity of functions converging on and reg-ulating the AR transcriptional complex. Endocr Rev 28:778-808 (Pubitemid 350294296)
92. Xu J, Qiu Y, DeMayo FJ, Tsai SY, Tsai MJ, O'Malley BW (1998) Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 279:1922-1925 (Pubitemid 28168645)
93. Gehin M, Mark M, Dennefeld C, Dierich A, Gronemeyer H, Chambon P (2002) The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. Mol Cell Biol 22:5923-5937 (Pubitemid 34815840)
94. Ting HJ, Chang C (2008) Actin associated proteins function as androgen receptor coregulators: an implication of androgen receptor's roles in skeletal muscle. J Steroid Biochem Mol Biol 111:157-163
95. Wyce A, Bai Y, Nagpal S, Thompson CC (2010) Research resource: the androgen receptor modulates expression of genes with critical roles in muscle development and function. Mol Endocrinol 24:1665-1674
96. Helsen C, Kerkhofs S, Clinckemalie L, Spans L, Laurent M, Boonen S, Vanderschueren D, Claessens F (2011) Structural basis for nuclear hormone receptor DNA binding. Mol Cell Endocrinol (Epub ahead of print)
97. Vlahopoulos S, Zimmer WE, Jenster G, Belaguli NS, Balk SP, Brinkmann AO, Lanz RB, Zoumpourlis VC, Schwartz RJ (2005) Recruitment of the androgen receptor via serum response factor facilitates expression of a myogenic gene. J Biol Chem 280:7786-7792 (Pubitemid 40349672)
98. Amir AL, Barua M, McKnight NC, Cheng S, Yuan X, Balk SP (2003) A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4. J Biol Chem 278:30828-30834 (Pubitemid 36994591)
99. Igarashi K, Kashiwagi K (2000) Polyamines: mysterious mod-ulators of cellular functions. Biochem Biophys Res Commun 271:559-564 (Pubitemid 30444667)
100. Turchanowa L, Rogozkin VA, Milovic V, Feldkoren BI, Casp-ary WF, Stein J (2000) Influence of physical exercise on polyamine synthesis in the rat skeletal muscle. Eur J Clin Invest 30:72-78 (Pubitemid 30071860)
101. Cepero M, Cubria JC, Reguera R, Balana-Fouce R, Ordonez C, Ordonez D (1998) Plasma and muscle polyamine levels in aerobically exercised rats treated with salbutamol. J Pharm Pharmacol 50:1059-1064 (Pubitemid 28464093)
102. Bardocz S, Brown DS, Grant G, Pusztai A, Stewart JC, Palmer RM (1992) Effect of the beta-adrenoceptor agonist clenbuterol and phytohaemagglutinin on growth, protein synthesis and polyamine metabolism of tissues of the rat Br J Pharmacol 106:476-482
103. Lee NK, Skinner JP, Zajac JD, Maclean HE (2011) Ornithine decarboxylase is up-regulated by the androgen receptor in skeletal muscle and regulates myoblast proliferation. Am J Physiol Endocrinol Metab 301:E172-E179
104. Crozat A, Palvimo JJ, Julkunen M, Janne OA (1992) Compar-ison of androgen regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase gene expression in rodent kidney and accessory sex organs. Endocrinology 130:1131-1144
105. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mecha-nism, and function. Cell 116:281-297
106. Stark A, Brennecke J, Bushati N, Russell RB, Cohen SM (2005) Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3'UTR evolution. Cell 123:1133-1146 (Pubitemid 41785426)
107. Jinek M, Doudna JA (2009) A three-dimensional view of the molecular machinery of RNA interference. Nature 457:405-412
108. O'Rourke JR, Georges SA, Seay HR, Tapscott SJ, McManus MT, Goldhamer DJ, Swanson MS, Harfe BD (2007) Essential role for Dicer during skeletal muscle development. Dev Biol 311:359-368 (Pubitemid 350046531)
109. Narayanan R, Jiang J, Gusev Y, Jones A, Kearbey JD, Miller DD, Schmittgen TD, Dalton JT (2010) MicroRNAs are media-tors of androgen action in prostate and muscle. PLoS One 5:e13637
110. van Rooij E, Liu N, Olson EN (2008) MicroRNAs flex their muscles. Trends Genet 24:159-166
111. Williams AH, Liu N, van Rooij E, Olson EN (2009) MicroRNA control of muscle development and disease. Curr Opin Cell Biol 21:461-469
112. Lai KM, Gonzalez M, Poueymirou WT, Kline WO, Na E, Zlotchenko E, Stitt TN, Economides AN, Yancopoulos GD, Glass DJ (2004) Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol 24:9295-9304 (Pubitemid 39391668)
113. Glass DJ (2005) Skeletal muscle hypertrophy and atrophy sig-naling pathways. Int J Biochem Cell Biol 37:1974-1984 (Pubitemid 41206815)
114. Allemand MC, Irving BA, Asmann YW, Klaus KA, Tatpati L, Coddington CC, Nair KS (2009) Effect of testosterone on insulin stimulated IRS1 Ser phosphorylation in primary rat myotubes\-a potential model for PCOS-related insulin resis-tance. PLoS One 4:e4274
115. Jones A, Hwang DJ, Narayanan R, Miller DD, Dalton JT (2010) Effects of a novel selective androgen receptor modulator on dexamethasone-induced and hypogonadism-induced muscle atrophy. Endocrinology 151:3706-3719
116. Ibebunjo C, Eash JK, Li C, Ma Q, Glass DJ (2011) Voluntary running, skeletal muscle gene expression, and signaling inver-sely regulated by orchidectomy and testosterone replacement. Am J Physiol Endocrinol Metab 300:E327-E340
117. Baron S, Manin M, Beaudoin C, Leotoing L, Communal Y, Veyssiere G, Morel L (2004) Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells. J Biol Chem 279:14579-14586 (Pubitemid 38618845)
118. McPherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387:83-90 (Pubitemid 27202654)
119. McPherron AC, Lee SJ (1997) Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci USA 94:12457-12461 (Pubitemid 27492550)
120. Mosher DS, Quignon P, Bustamante CD, Sutter NB, Mellersh CS, Parker HG, Ostrander EA (2007) A mutation in the myo-statin gene increases muscle mass and enhances racing performance in heterozygote dogs. PLoS Genet 3:e79
121. Reisz-Porszasz S, Bhasin S, Artaza JN, Shen R, Sinha-Hikim I, Hogue A, Fielder TJ, Gonzalez-Cadavid NF (2003) Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. Am J Physiol Endocrinol Metab 285:E876-E888 (Pubitemid 37176437)
122. Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J, Kambadur R (2000) Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 275:40235-40243 (Pubitemid 32064654)
123. Taylor WE, Bhasin S, Artaza J, Byhower F, Azam M, Willard DH Jr, Kull FC Jr, Gonzalez-Cadavid N (2001) Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am J Physiol Endocrinol Metab 280:E221-E228
124. Rios R, Carneiro I, Arce VM, Devesa J (2002) Myostatin is an inhibitor of myogenic differentiation. Am J Physiol Cell Physiol 282:C993-C999 (Pubitemid 34663107)
125. Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, Kambadur R (2002) Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 277: 49831-49840 (Pubitemid 36014431)
126. Joulia D, Bernardi H, Garandel V, Rabenoelina F, Vernus B, Cabello G (2003) Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp Cell Res 286:263-275 (Pubitemid 36566439)
127. McFarlane C, Plummer E, Thomas M, Hennebry A, Ashby M, Ling N, Smith H, Sharma M, Kambadur R (2006) Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mecha-nism. J Cell Physiol 209:501-514 (Pubitemid 44484641)
128. Wagner KR, Liu X, Chang X, Allen RE (2005) Muscle regen-eration in the prolonged absence of myostatin. Proc Natl Acad Sci USA 102:2519-2524 (Pubitemid 40279409)
129. McCroskery S, Thomas M, Maxwell L, Sharma M, Kambadur R (2003) Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 162:1135-1147 (Pubitemid 37174195)
130. McFarlane C, Hennebry A, Thomas M, Plummer E, Ling N, Sharma M, Kambadur R (2008) Myostatin signals through Pax7 to regulate satellite cell self-renewal. Exp Cell Res 314:317-329 (Pubitemid 350225602)
131. Amthor H, Otto A, Vulin A, Rochat A, Dumonceaux J, Garcia L, Mouisel E, Hourde C, Macharia R, Friedrichs M, Relaix F, Zammit PS, Matsakas A, Patel K, Partridge T (2009) Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity. Proc Natl Acad Sci USA 106:7479-7484
132. McPherron AC, Lee SJ (2002) Suppression of body fat accu-mulation in myostatin-deficient mice. J Clin Invest 109:595-601 (Pubitemid 34204838)
133. Lin J, Arnold HB, Della-Fera MA, Azain MJ, Hartzell DL, Baile CA (2002) Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem Biophys Res Commun 291:701-706 (Pubitemid 34687403)
134. Artaza JN, Bhasin S, Magee TR, Reisz-Porszasz S, Shen R, Groome NP, Meerasahib MF, Gonzalez-Cadavid NF (2005) Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multipotent cells. Endocrinology 146:3547-3557 (Pubitemid 41058126)
135. Seuntjens E, Umans L, Zwijsen A, Sampaolesi M, Verfaillie CM, Huylebroeck D (2009) Transforming Growth Factor type beta and Smad family signaling in stem cell function. Cytokine Growth Factor Rev 20:449-458
136. Gilson H, Schakman O, Kalista S, Lause P, Tsuchida K, Thissen JP (2009) Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin. Am J Physiol Endocrinol Metab 297:E157-E164
137. Amthor H, Nicholas G, McKinnell I, Kemp CF, Sharma M, Kambadur R, Patel K (2004) Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Dev Biol 270:19-30 (Pubitemid 38596926)
138. Hill JJ, Davies MV, Pearson AA, Wang JH, Hewick RM, Wolfman NM, Qiu Y (2002) The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myo-statin in normal serum. J Biol Chem 277:40735-40741 (Pubitemid 35215657)
139. Mendler L, Baka Z, Kovacs-Simon A, Dux L (2007) Androgens negatively regulate myostatin expression in an androgen-dependent skeletal muscle. Biochem Biophys Res Commun 361:237-242 (Pubitemid 47102291)
140. Gentile MA, Nantermet PV, Vogel RL, Phillips R, Holder D, Hodor P, Cheng C, Dai H, Freedman LP, Ray WJ (2010) Androgen-mediated improvement of body composition and muscle function involves a novel early transcriptional program including IGF1, mechano growth factor, and induction of {beta}-catenin. J Mol Endocrinol 44:55-73
141. Zhao JX, Hu J, Zhu MJ, Du M (2011) Trenbolone enhances myogenic differentiation by enhancing beta-catenin signaling in muscle-derived stem cells of cattle. Domest Anim Endocrinol 40:222-229
142. Ma K, Mallidis C, Artaza J, Taylor W, Gonzalez-Cadavid N, Bhasin S (2001) Characterization of 5'-regulatory region of human myostatin gene: regulation by dexamethasone in vitro. Am J Physiol Endocrinol Metab 281:E1128-E1136
143. Laviola L, Natalicchio A, Giorgino F (2007) The IGF-I signaling pathway. Curr Pharm Des 13:663-669 (Pubitemid 46510743)
144. Shavlakadze T, Winn N, Rosenthal N, Grounds MD (2005) Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle. Growth Horm IGF Res 15:4-18 (Pubitemid 40220850)
145. Florini JR, Ewton DZ, Coolican SA (1996) Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17:481-517 (Pubitemid 26346639)
146. Frost RA, Lang CH (2003) Regulation of insulin-like growth factor-I in skeletal muscle and muscle cells. Minerva Endocrinol 28:53-73
147. Sacheck JM, Ohtsuka A, McLary SC, Goldberg AL (2004) IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am J Physiol Endocrinol Metab 287:E591-E601 (Pubitemid 39242684)
148. Hameed M, Lange KH, Andersen JL, Schjerling P, Kjaer M, Harridge SD, Goldspink G (2004) The effect of recombinant human growth hormone and resistance training on IGF-I mRNA expression in the muscles ofelderly men. J Physiol 555:231-240 (Pubitemid 38313073)
149. Goldspink G, Harridge SD (2004) Growth factors and muscle ageing. Exp Gerontol 39:1433-1438 (Pubitemid 39410542)
150. Yang SY, Goldspink G (2002) Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Lett 522:156-160 (Pubitemid 34722516)
151. Keenan BS, Richards GE, Ponder SW, Dallas JS, Nagamani M, Smith ER (1993) Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty. J Clin Endocrinol Metab 76:996-1001 (Pubitemid 23110851)
152. Ulloa-Aguirre A, Blizzard RM, Garcia-Rubi E, Rogol AD, Link K, Christie CM, Johnson ML, Veldhuis JD (1990) Testosterone and oxandrolone, a nonaromatizable androgen, specifically amplify the mass and rate of growth hormone (GH) secreted per burst without altering GH secretory burst duration or frequency or the GH half-life. J Clin Endocrinol Metab 71:846-854
153. Bhasin S, Woodhouse L, Casaburi R, Singh AB, Bhasin D, Berman N, Chen X, Yarasheski KE, Magliano L, Dzekov C, Dzekov J, Bross R, Phillips J, Sinha-Hikim I, Shen R, Storer TW (2001) Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 281:E1172-E1181
154. Serra C, Bhasin S, Tangherlini F, Barton ER, Ganno M, Zhang A, Shansky J, Vandenburgh HH, Travison TG, Jasuja R, Morris C (2011) The role of GH and IGF-I in mediating anabolic effects of testosterone on androgen-responsive muscle. Endocrinology 152:193-206
155. Xu T, Shen Y, Pink H, Triantafillou J, Stimpson SA, Turnbull P, Han B (2004) Phosphorylation of p70s6 kinase is implicated in androgen-induced levator ani muscle anabolism in castrated rats. J Steroid Biochem Mol Biol 92:447-454 (Pubitemid 40192528)
156. Kamanga-Sollo E, Pampusch MS, Xi G, White ME, Hathaway MR, Dayton WR (2004) IGF-I mRNA levels in bovine satellite cell cultures: effects of fusion and anabolic steroid treatment. J Cell Physiol 201:181-189 (Pubitemid 39305096)
157. Wu Y, Zhao W, Zhao J, Pan J, Wu Q, Zhang Y, Bauman WA, Cardozo CP (2007) Identification of androgen response elements in the insulin-like growth factor I upstream promoter. Endocri-nology 148:2984-2993 (Pubitemid 46984806)
158. Chambon C, Duteil D, Vignaud A, Ferry A, Messaddeq N, Malivindi R, Kato S, Chambon P, Metzger D (2010) Myocytic androgen receptor controls the strength but not the mass of limb muscles. Proc Natl Acad Sci USA 107:14327-14332
159. Dardevet D, Sornet C, Vary T, Grizard J (1996) Phosphatidyl-inositol 3-kinase and p70 s6 kinase participate in the regulation of protein turnover in skeletal muscle by insulin and insulin-like growth factor I. Endocrinology 137:4087-4094 (Pubitemid 26321849)
160. Kim HJ, Lee WJ (2009) Insulin-like growth factor-I induces androgen receptor activation in differentiating C2C12 skeletal muscle cells. Mol Cells 28:189-194
161. Lee WJ (2009) Insulin-like growth factor-I-induced androgen receptor activation is mediated by the PI3 K/Akt pathway in C2C12 skeletal muscle cells. Mol Cells 28:495-499
162. Brown D, Hikim AP, Kovacheva EL, Sinha-Hikim I (2009) Mouse model of testosterone-induced muscle fiber hypertrophy: involvement of p38 mitogen-activated protein kinase-mediated Notch signaling. J Endocrinol 201:129-139
163. Kovacheva EL, Hikim AP, Shen R, Sinha I, Sinha-Hikim I (2010) Testosterone supplementation reverses sarcopenia in aging through regulation of myostatin, c-Jun NH2-terminal kinase, Notch, and Akt signaling pathways. Endocrinology 151:628-638
164. Bedogni B, Warneke JA, Nickoloff BJ, Giaccia AJ, Powell MB (2008) Notch1 is an effector of Akt and hypoxia in melanoma development. J Clin Invest 118:3660-3670
165. Wehling M (1997) Specific, nongenomic actions of steroid hormones. Annu Rev Physiol 59:365-393 (Pubitemid 27142447)
166. Cato AC, Nestl A, Mink S (2002) Rapid actions of steroid receptors in cellular signaling pathways. Sci STKE 2002(138): re9
167. Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C, Auricchio F (2000) Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J 19:5406-5417
168. Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzen-ellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC (2001) Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104:719-730 (Pubitemid 32241022)
169. Nakhla AM, Rosner W (1996) Stimulation of prostate cancer growth by androgens and estrogens through the intermediacy of sex hormone-binding globulin. Endocrinology 137:4126-4129 (Pubitemid 26321856)
170. Kampa M, Papakonstanti EA, Hatzoglou A, Stathopoulos EN, Stournaras C, Castanas E (2002) The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors that increase PSA secretion and modify actin cytoskeleton. FASEB J 16:1429-1431
171. Benten WP, Lieberherr M, Giese G, Wrehlke C, Stamm O, Sekeris CE, Mossmann H, Wunderlich F (1999) Functional testosterone receptors in plasma membranes of T cells. FASEB J 13:123-133 (Pubitemid 29038282)
172. Yeh S, Lin HK, Kang HY, Thin TH, Lin MF, Chang C (1999) From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc Natl Acad Sci USA 96:5458-5463 (Pubitemid 29234639)
173. Lopez GN, Turck CW, Schaufele F, Stallcup MR, Kushner PJ (2001) Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation ofp160 coactivator activity. J Biol Chem 276:22177-22182
174. Schneider MD, Olson EN (1988) Control of myogenic differ-entiation by cellular oncogenes. Mol Neurobiol 2:1-39
175. Falcone G, Alema S, Tato F (1991) Transcription of muscle-specific genes is repressed by reactivation of pp60v-src in postmitotic quail myotubes. Mol Cell Biol 11:3331-3338 (Pubitemid 21895721)
176. Hamdi MM, Mutungi G (2010) Dihydrotestosterone activates the MAPK pathway and modulates maximum isometric force through the EGF receptor in isolated intact mouse skeletal muscle fibres. J Physiol 588:511-525
177. Siiteri PK, Murai JT, Hammond GL, Nisker JA, Raymoure WJ, Kuhn RW (1982) The serum transport of steroid hormones. Recent Prog Horm Res 38:457-510
178. Krupenko SA, Krupenko NI, Danzo BJ (1994) Interaction of sex hormone-binding globulin with plasma membranes from the rat epididymis and other tissues. J Steroid Biochem Mol Biol 51:115-124 (Pubitemid 24340053)
179. Nazareth LV, Weigel NL (1996) Activation of the human androgen receptor through a protein kinase A signaling pathway. J Biol Chem 271:19900-19907 (Pubitemid 26281734)
180. Sadar MD (1999) Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways. J Biol Chem 274:7777-7783
181. Fortunati N (1999) Sex hormone-binding globulin: not only a transport protein. What news is around the corner? J Endocrinol Invest 22:223-234 (Pubitemid 29158645)
182. Rosner W, Hryb DJ, Kahn SM, Nakhla AM, Romas NA (2010) Interactions of sex hormone-binding globulin with target cells. Mol Cell Endocrinol 316:79-85
183. Benten WP, Lieberherr M, Stamm O, Wrehlke C, Guo Z, Wunderlich F (1999) Testosterone signaling through internal-izable surface receptors in androgen receptor-free macrophages. Mol Biol Cell 10:3113-3123 (Pubitemid 29489549)
184. Estrada M, Espinosa A, Muller M, Jaimovich E (2003) Tes-tosterone stimulates intracellular calcium release and mitogen-activated protein kinases via a G protein-coupled receptor in skeletal muscle cells. Endocrinology 144:3586-3597 (Pubitemid 36904438)
185. Mellstrom B, Naranjo JR (2001) Mechanisms of Ca(2 +)-dependent transcription. Curr Opin Neurobiol 11:312-319
186. Fu R, Liu J, Fan J, Li R, Li D, Yin J, Cui S (2011) Novel evidence that testosterone promotes cell proliferation and dif-ferentiation via G protein-coupled receptors in the rat L6 skeletal muscle myoblast cell line. J Cell Physiol 227:98-107
187. Thum T, Springer J (2011) Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?! J Cachex Sarcopenia Muscle 2:121-123
188. Whittemore LA, Song K, Li X, Aghajanian J, Davies M, Gir-genrath S, Hill JJ, Jalenak M, Kelley P, Knight A, Maylor R, O'Hara D, Pearson A, Quazi A, Ryerson S, Tan XY, Tomkinson KN, Veldman GM, Widom A, Wright JF, Wudyka S, Zhao L, Wolfman NM (2003) Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 300:965-971 (Pubitemid 36262030)
189. Rose FF Jr, Mattis VB, Rindt H, Lorson CL (2009) Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy. Hum Mol Genet 18:997-1005
190. Mohler ML, Bohl CE, Jones A, Coss CC, Narayanan R, He Y, Hwang DJ, Dalton JT, Miller DD (2009) Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the ana-bolic and androgenic activities of the androgen receptor for therapeutic benefit J Med Chem 52:3597-3617
191. Wright AS, Douglas RC, Thomas LN, Lazier CB, Rittmaster RS (1999) Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase. Endocrinology 140:4509-4515 (Pubitemid 30666115)
192. Kazmin D, Prytkova T, Cook CE, Wolfinger R, Chu TM, Ber-atan D, Norris JD, Chang CY, McDonnell DP (2006) Linking ligand-induced alterations in androgen receptor structure to differential gene expression: a first step in the rational design of selective androgen receptor modulators. Mol Endocrinol 20:1201-1217 (Pubitemid 43801226)
193. Narayanan R, Coss CC, Yepuru M, Kearbey JD, Miller DD, Dalton JT (2008) Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathways. Mol Endocrinol 22:2448-2465
194. Dalton JT, Barnette KG, Bohl CE, Hancock ML, Rodriguez D, Dodson ST, Morton RA, Steiner MS (2011) The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J Cachex Sarcopenia Muscle 2:153-161